As Wentworth-Douglass Hospital is preparing to celebrate its 120th anniversary, its CEO touts major care improvements under ...

J&J Medtech has launched the latest version of its pulsed ablation device after receiving CE Mark approval in Europe. The ...

The complete study cohort includes 1,023 patients from 22 sites in Europe.

The Society of Interventional Radiology (SIR) announced that the CAPTAIN randomized clinical trial found that men with ...

Living with lower back pain? You may qualify for a minimally invasive procedure at UP Health System Marquette.

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, ...

A recent randomized clinical trial has found that men with localized, intermediate-risk prostate cancer recovered faster and ...

A MONK Bretton man has become one of the first in the country to undergo a pioneering procedure for a heart condition.Sh...

Medical City McKinney is offering a new procedure called Left Atrial Appendage Closure, which is designed to reduce the risk of stroke without blood-thinning medication, according to an April 9 news ...

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the U.S.

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...

A new randomized clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster and ...